Jorge Nieva is an Oncology physician affiliated with University of Southern California. OpenAlex indexes 413 publications with 8,901 citations (h-index 41); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1441 Eastlake Ave
Nor8302e
Los Angeles, CA 900890177
Telephone
323-865-3105Provider last certified this registry record 28 Aug 2020.
Clinical trials
- Precision Performance Status Compared With ECOG Performance Status
Sponsor: University of Southern California
- Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer
Sponsor: University of Southern California
- Epidemiology of Young Lung Cancer - Survey
Sponsor: Addario Lung Cancer Medical Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
30 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UROGEN PHARMA, INC.Program year20257 payments
- PFIZER INC.Program year20255 payments
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Advancing Digital Health Innovation in Oncology: Priorities for High-Value Digital Transformation in Cancer Care
Journal of Medical Internet Research
2023 - NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types
British Journal of Cancer
2021 - A Systematic Review of the Efficacy of Preclinical Models of Lung Cancer Drugs
Frontiers in Oncology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”